{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:02:05Z","timestamp":1780984925866,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CORPG8N0271"],"award-info":[{"award-number":["CORPG8N0271"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8L0181"],"award-info":[{"award-number":["CMRPG8L0181"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8L0182"],"award-info":[{"award-number":["CMRPG8L0182"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13304-025-02447-z","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T05:41:59Z","timestamp":1760679719000},"page":"1167-1177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The association between antiviral therapy and 10-year overall survival of patients undergoing liver resection for hepatitis C virus- or hepatitis B virus-related hepatocellular carcinoma"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6251-7230","authenticated-orcid":false,"given":"Yi-Hao","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Houng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hung","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee-Chien","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"2447_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"2447_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32723","author":"JL Petrick","year":"2019","unstructured":"Petrick JL, Florio AA, Znaor A, Ruggieri D, Laversanne M, Alvarez CS, Ferlay J et al (2019) International trends in hepatocellular carcinoma incidence, 1978\u20132012. Int J Cancer. https:\/\/doi.org\/10.1002\/ijc.32723","journal-title":"Int J Cancer"},{"issue":"7","key":"2447_CR3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","volume":"34","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R (2022) Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab 34(7):969-977.e2. https:\/\/doi.org\/10.1016\/j.cmet.2022.05.003","journal-title":"Cell Metab"},{"key":"2447_CR4","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hep.32758","volume":"77","author":"DJH Tan","year":"2023","unstructured":"Tan DJH, Setiawan VW, Ng CH, Lim WH, Muthiah MD, Tan EX et al (2023) Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH. Hepatology 77:1150\u20131163. https:\/\/doi.org\/10.1002\/hep.32758","journal-title":"Hepatology"},{"key":"2447_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Huang DQ, Nguyen MH (2023) Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol 20:524\u2013537","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2447_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723\u2013750. https:\/\/doi.org\/10.1002\/hep.29913","journal-title":"Hepatology"},{"key":"2447_CR7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer","year":"2012","unstructured":"European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASLEORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908\u2013943. https:\/\/doi.org\/10.1016\/j.jhep.2011.12.001","journal-title":"J Hepatol"},{"issue":"7","key":"2447_CR8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1200\/JCO.23.00757","volume":"42","author":"DQ Huang","year":"2024","unstructured":"Huang DQ, Hoang JK, Kamal R, Tsai PC, Toyoda H, Yeh ML et al (2024) Antiviral therapy utilization and 10-year outcomes in resected Hepatitis B virus\u2013 and Hepatitis C virus-related hepatocellular carcinoma. J Clin Oncol 42(7):790\u2013799. https:\/\/doi.org\/10.1200\/JCO.23.00757","journal-title":"J Clin Oncol"},{"key":"2447_CR9","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.2147\/OTT.S150281","volume":"10","author":"XX Chen","year":"2017","unstructured":"Chen XX, Cheng JW, Huang A, Zhang X, Wang J, Fan J, Zhou J et al (2017) The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis. Onco Targets Ther 10:5363\u20135375. https:\/\/doi.org\/10.2147\/OTT.S150281","journal-title":"Onco Targets Ther"},{"key":"2447_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-016-0089-z","author":"JL Chen","year":"2016","unstructured":"Chen JL, Lin XJ, Zhou Q, Shi M, Li SP, Lao XM (2016) Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection. Chin J Cancer. https:\/\/doi.org\/10.1186\/s40880-016-0089-z","journal-title":"Chin J Cancer"},{"key":"2447_CR11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/ijc.30521","volume":"140","author":"S Manthravadi","year":"2017","unstructured":"Manthravadi S, Paleti S, Pandya P (2017) Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis. Int J Cancer 140:1042\u20131049. https:\/\/doi.org\/10.1002\/ijc.30521","journal-title":"Int J Cancer"},{"key":"2447_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/jvh.13627","volume":"29","author":"H Ikenaga","year":"2022","unstructured":"Ikenaga H, Uchida-Kobayashi S, Tamori A, Odagiri N, Yoshida K, Kotani K et al (2022) Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment. J Viral Hepat 29:52\u201359. https:\/\/doi.org\/10.1111\/jvh.13627","journal-title":"J Viral Hepat"},{"key":"2447_CR13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-16453-9","author":"H Abe","year":"2024","unstructured":"Abe H, Okamura Y, Yoshida N, Mitsuka Y, Aramaki O, Moriguchi M et al (2024) Impact of sustained virological response on long-term outcomes after curative resection in patients with hepatitis C virus-related hepatocellular carcinoma in the era of direct-acting antiviral therapy. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-024-16453-9","journal-title":"Ann Surg Oncol"},{"key":"2447_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jhep.2019.03.027","volume":"71","author":"G Cabibbo","year":"2019","unstructured":"Cabibbo G, Celsa C, Calvaruso V, Petta S, Cacciola I, Cannav\u00f2 MR et al (2019) Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients. J Hepatol 71:265\u2013273. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.027","journal-title":"J Hepatol"},{"key":"2447_CR15","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.hpb.2024.04.014","volume":"26","author":"C Rocha","year":"2024","unstructured":"Rocha C, Di Norcia J, Tabrizian P, Di Renzo C, Amodeo S, Bekki Y et al (2024) Improved outcomes of liver resection for hepatitis C-related hepatocellular carcinoma after the introduction of direct-acting antiviral therapy. HPB (Oxford) 26:1007\u20131021. https:\/\/doi.org\/10.1016\/j.hpb.2024.04.014","journal-title":"HPB (Oxford)"},{"key":"2447_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/liv.12576","volume":"35","author":"E Akhtar","year":"2015","unstructured":"Akhtar E, Manne V, Saab S (2015) Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis. Liver Int 35:30\u201336. https:\/\/doi.org\/10.1111\/liv.12576","journal-title":"Liver Int"},{"key":"2447_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/liv.12395","volume":"34","author":"V Calvaruso","year":"2014","unstructured":"Calvaruso V, Crax\u00ec A (2014) Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? Liver Int 34:85\u201390. https:\/\/doi.org\/10.1111\/liv.12395","journal-title":"Liver Int"},{"key":"2447_CR18","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1097\/MCG.0000000000000162","volume":"48","author":"V Manne","year":"2014","unstructured":"Manne V, Akhtar E, Saab S (2014) Cirrhosis regression in patients with viral hepatitis B and C: a systematic review. J Clin Gastroenterol 48:e76-84. https:\/\/doi.org\/10.1097\/MCG.0000000000000162","journal-title":"J Clin Gastroenterol"},{"key":"2447_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329\u2013338. https:\/\/doi.org\/10.1055\/s-2007-1007122","journal-title":"Semin Liver Dis"},{"key":"2447_CR20","first-page":"175","volume-title":"American Joint Committee on Cancer Staging Manual. 7th ed, Edge SB, Byrd DR, Compton CC, et al (Eds)","author":"American Joint Committee on Cancer","year":"2010","unstructured":"American Joint Committee on Cancer (2010) American Joint Committee on Cancer Staging Manual. 7th ed, Edge SB, Byrd DR, Compton CC, et al (Eds). Springer, New York p, p 175"},{"key":"2447_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/hep.23315","volume":"51","author":"JE Everhart","year":"2010","unstructured":"Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE et al (2010) Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 51:585\u2013594","journal-title":"Hepatology"},{"key":"2447_CR22","unstructured":"NCI dictionary of cancer terms. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms"},{"key":"2447_CR23","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB, American Association for the Study of Liver Diseases (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49:1335\u20131374. https:\/\/doi.org\/10.1002\/hep.22759","journal-title":"Hepatology"},{"key":"2447_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31060","volume":"71","author":"MG Ghany","year":"2020","unstructured":"Ghany MG, Morgan TR, AASLD-IDSA Hepatitis C Guidance Panel (2020) Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology 71:686\u2013721. https:\/\/doi.org\/10.1002\/hep.31060","journal-title":"Hepatology"},{"key":"2447_CR25","volume-title":"Statistical power analysis for the behavioral science","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral science, 2nd edn. Department of Psychology, New York University, Lawrence Erlbaum Associates, New York","edition":"2"},{"key":"2447_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1478-3231.2007.01625.x","volume":"28","author":"BK Kim","year":"2008","unstructured":"Kim BK, Park JY, Kim Y, Kim JK, Kim KS, Choi JS et al (2008) Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. Liver Int 28:393\u2013401. https:\/\/doi.org\/10.1111\/j.1478-3231.2007.01625.x","journal-title":"Liver Int"},{"issue":"2","key":"2447_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cgh.2009.10.026","volume":"8","author":"AK Singal","year":"2010","unstructured":"Singal AK, Singh A, Jaganmohan S, Guturu P, Mummadi R, Kuo YF et al (2010) Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 8(2):192\u2013199. https:\/\/doi.org\/10.1016\/j.cgh.2009.10.026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2447_CR28","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/s0140-6736(95)91739-x","volume":"346","author":"S Nishiguchi","year":"1995","unstructured":"Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S et al (1995) Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346:1051\u20131055. https:\/\/doi.org\/10.1016\/s0140-6736(95)91739-x","journal-title":"Lancet"},{"key":"2447_CR29","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/j.1349-7006.1999.tb00680.x","volume":"90","author":"S Kubo","year":"1999","unstructured":"Kubo S, Yamamoto T, Ikebe T, Shuto T, Hirohashi K, Tanaka H et al (1999) Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C. Jpn J Cancer Res 90:1076\u20131080. https:\/\/doi.org\/10.1111\/j.1349-7006.1999.tb00680.x","journal-title":"Jpn J Cancer Res"},{"key":"2447_CR30","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/ajg.2009.173","volume":"104","author":"S Yu","year":"2009","unstructured":"Yu S, Douglass JM, Qualls C, Arora S, Dunkelberg JC (2009) Response to therapy with pegylated interferon and ribavirin for chronic hepatitis C in Hispanics compared to non-Hispanic whites. Am J Gastroenterol 104:1686\u20131692","journal-title":"Am J Gastroenterol"},{"key":"2447_CR31","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1073\/pnas.92.10.4562","volume":"92","author":"RK Singh","year":"1995","unstructured":"Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ (1995) Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci U S A 92:4562\u20134566","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/hep.1840170307","volume":"17","author":"CL Lai","year":"1993","unstructured":"Lai CL, Lau JY, Wu PC, Ngan H, Chung HT, Mitchell SJ et al (1993) Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology 17:389\u2013394","journal-title":"Hepatology"},{"key":"2447_CR33","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM et al (2018) Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67:1560\u20131599. https:\/\/doi.org\/10.1002\/hep.29800","journal-title":"Hepatology"},{"issue":"3","key":"2447_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.14701\/kjhbps.2012.16.3.98","volume":"16","author":"KH Kim","year":"2012","unstructured":"Kim KH, Choi YK (2012) Long-term survival after resection of hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg 16(3):98\u2013104. https:\/\/doi.org\/10.14701\/kjhbps.2012.16.3.98","journal-title":"Korean J Hepatobiliary Pancreat Surg"},{"key":"2447_CR35","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/2012.jama.11975","volume":"308","author":"CY Wu","year":"2012","unstructured":"Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS et al (2012) Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 308:1906\u20131914. https:\/\/doi.org\/10.1001\/2012.jama.11975","journal-title":"JAMA"},{"key":"2447_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejim.2022.10.026","volume":"107","author":"B Yun","year":"2023","unstructured":"Yun B, Ahn SH, Oh J, Yoon JH, Kim BK (2023) Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: a nationwide study. Eur J Intern Med 107:66\u201372. https:\/\/doi.org\/10.1016\/j.ejim.2022.10.026","journal-title":"Eur J Intern Med"},{"key":"2447_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11605-019-04277-y","volume":"24","author":"J Shindoh","year":"2020","unstructured":"Shindoh J, Kawamura Y, Kobayashi Y, Akuta N, Kobayashi M, Suzuki Y et al (2020) Time-to-interventional failure as a new surrogate measure for survival outcomes after resection of hepatocellular carcinoma. J Gastrointest Surg 24:50\u201357. https:\/\/doi.org\/10.1007\/s11605-019-04277-y","journal-title":"J Gastrointest Surg"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02447-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02447-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02447-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:37:38Z","timestamp":1780983458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-025-02447-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2447"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02447-z","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose for all authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board of Kaohsiung Chang Gung Memorial Hospital approved this study (Reference number: 202400371B0) and waived the need for informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The Institutional Review Board of Kaohsiung Chang Gung Memorial Hospital approved this study (Reference number: 202400371B0) and waived the need for informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals, and Informed consent"}}]}}